Conference Proceedings

ImmunoPET: A Phase 0/1 Study Characterising PD-L1 with 89Zr-Durvalumab (MEDI4736) PET/CT in Stage III NSCLC Patients Receiving Chemoradiation

M MacManus, S Rudd, P Roselt, C Wichmann, J Callahan, T John, A Scott, P Donnelly, G Hanna, F Hegi-Johnson

JOURNAL OF THORACIC ONCOLOGY | ELSEVIER SCIENCE INC | Published : 2022

DOI: 10.1016/j.jtho.2022.07.180

Citation metrics

1Web of Science
1Dimensions

Keywords

Clinical Trials and Supportive Activities
3202 Clinical Sciences
32 Biomedical and Clinical Sciences
Cancer
Pet Imaging
Life Sciences & Biomedicine
Respiratory System
Clinical Research
Non-Small Cell Lung Cancer
Oncology
Immunotherapy
Science & Technology
Radiation Oncology
Biomedical Imaging